Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
18,399
Value
$623.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,399$623.4K<0.1%−3,489−15.9%ReducedHolders
Q1 202621,888$659.3K<0.1%+903+4.3%AddedHolders
Q4 202520,985$654.9K<0.1%+8,145+63.4%AddedHolders
Q3 202512,840$259.4K<0.1%+261+2.1%AddedHolders
Q2 202512,579$210.8K<0.1%−248−1.9%ReducedHolders
Q1 202512,827$197.2K<0.1%−12,788−49.9%ReducedHolders
Q4 202425,615$564.6K<0.1%−489−1.9%ReducedHolders
Q3 202426,104$470.4K<0.1%+2,990+12.9%AddedHolders
Q2 202423,114$375.9K<0.1%+1,093+5.0%AddedHolders
Q1 202422,021$310.2K<0.1%+2,597+13.4%AddedHolders
Q4 202319,424$203.9K<0.1%+4,654+31.5%AddedHolders
Q3 202314,770$147.0K<0.1%+1,790+13.8%AddedHolders
Q2 202312,980$97.7K<0.1%−200−1.5%ReducedHolders
Q1 202313,180$116.6K<0.1%00.0%UnchangedHolders
Q4 202213,180$120<0.1%−1,227−8.5%ReducedHolders
Q3 202214,407$116.0K<0.1%−10,261−41.6%ReducedHolders
Q2 202224,668$185.0K<0.1%+10,851+78.5%AddedHolders
Q1 202213,817$130.0K<0.1%−1,330−8.8%ReducedHolders
Q4 202115,147$121.0K<0.1%−1,195−7.3%ReducedHolders
Q3 202116,342$159.0K<0.1%−21−0.1%ReducedHolders
Q2 202116,363$162.0K<0.1%+585+3.7%AddedHolders
Q1 202115,778$182.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.